-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 OXGttq8addH+1IS5/Ty0C7vN2aRPK8y5Pa5iyUmbnwht0Y70y9Sbir7xM3trOs59
 i4N1ZItywNnRwuzHOjEKsw==

<SEC-DOCUMENT>0000950133-05-004931.txt : 20051104
<SEC-HEADER>0000950133-05-004931.hdr.sgml : 20051104
<ACCEPTANCE-DATETIME>20051104091643
ACCESSION NUMBER:		0000950133-05-004931
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20051104
FILED AS OF DATE:		20051104
DATE AS OF CHANGE:		20051104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVOGEN LTD
		CENTRAL INDEX KEY:			0001075880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29962
		FILM NUMBER:		051178668

	BUSINESS ADDRESS:	
		STREET 1:		140 WICKS RD
		STREET 2:		NORTH RYDE
		CITY:			NEW SOUTH WALES 2113
		STATE:			C3
		ZIP:			2113
		BUSINESS PHONE:		01161298780088

	MAIL ADDRESS:	
		STREET 1:		107 NORTH RYDE
		CITY:			SYDNEY
		STATE:			C3
		ZIP:			1670
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>w14381e6vk.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
<TITLE>e6vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<P align="center"><FONT size="4"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></FONT>

<DIV align="center"><B><FONT size="3">Washington. D.C. 20549</FONT></B></DIV>

<P align="center"><FONT size="5"><b>Form&nbsp;6-K</b></FONT>

<P align="center"><FONT size="2"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<BR>
UNDER THE SECURITIES EXCHANGE ACT OF 1934</B>
</FONT>

<P align="left"><FONT size="2">For the month of <B>November 2005</B>
</FONT>
<P align="center"><FONT size="6"><B>Novogen Limited</B></FONT>

<DIV align="center"><FONT size="2">(Translation of registrant&#146;s name into English)</FONT></DIV>

<P align="center"><FONT size="2"><B>140 Wicks Road, North Ryde, NSW, 2113, Australia</B><BR>
(Address of principal executive office)
</FONT>
<P><FONT size="2">&#091;Indicate by check mark whether the registrant files or will file annual
reports under cover of Form&nbsp;20-F or Form&nbsp;40-F.
Form&nbsp;20-F <FONT face="Wingdings">&#120;</FONT> Form&nbsp;40-F <FONT face="Wingdings">&#111;</FONT>
</FONT>
<P><FONT size="2">&#091;Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule&nbsp;12g3-2(b) under the Securities Exchange Act of
1934. Yes <FONT face="Wingdings">&#111;</FONT> No
<FONT face="Wingdings">&#111;</FONT>
</FONT>
<P><FONT size="2">&#091;If &#147;Yes&#148; is marked, indicate below the file number assigned to the registrant in connection with Rule&nbsp;12g3-2 (b):
82-
<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>.1</font>
<P align="center"><FONT size="2">&nbsp;</FONT>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: Helvetica,Arial,sans-serif">



<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><IMG src="w14381logo.gif" alt="(Novogen Logo)">
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>ASX &#038; MEDIA RELEASE<BR>
4 NOVEMBER, 2005<br><BR>
NOVOGEN ANNOUNCEMENT</B>

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">At its Annual General Meeting held on 28 October&nbsp;2005, the Chairman advised shareholders that the
Company would be seeking to ascertain the reasons why a significant number of proxy votes had been
cast against Resolution 2, which related to the adoption of the Remuneration Report for the year
ended 30 June&nbsp;2005, to determine whether there was a need for the Company to review its
remuneration policies.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company disclosed to ASX on 28 October&nbsp;2005 that 4,629,522 proxy votes had been cast in favour
of Resolution 2 and 12,193,974 proxy votes had been cast against Resolution 2.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">The Company has commenced its inquiry and has now been informed that 3 shareholders holding more
than 12,000,000 of the shares representing the proxy votes cast against Resolution 2 retain a third
party independent proxy voting agent. Due to a voting systems error, those 3 shareholders were not
given the opportunity to give voting instructions on Resolution 2 when they should have been. The
Company has been advised that if the voting systems error had not occurred and voting instructions
had been sought, those 3 shareholders would have voted for Resolution 2. Those shareholders have
apologised to the Company for this voting error and for any confusion the incorrect vote has
caused. Whilst this does not impact on the validity of the proxy votes cast it is a factor that the
Company will take into account in determining whether it needs to review its remuneration policies.
</DIV>

<DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 100%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="20%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><B>ISSUED FOR</B></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>:</B></TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><B>NOVOGEN LIMITED</B></TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><B>LISTINGS</B></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><B>:</B></TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>ASX (CODE NRT), NASDAQ (CODE NVGN).</B></TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px"><B>FOR FURTHER</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><B>INFORMATION :</B></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>:</B></TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><B>MR CHRISTOPHER NAUGHTON, MANAGING DIRECTOR, NOVOGEN LIMITED</B></TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>TEL (02)&nbsp;9878 0088</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><U>http://www.novogen.com</U></TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: Helvetica,Arial,sans-serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><IMG src="w14381logo.gif" alt="(Novogen Logo)">
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">3 November&nbsp;2005<br>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Dear Novogen Shareholder<br>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>Novogen Limited (Novogen) &#151; Results of Annual General Meeting</B>

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">I am writing to you to clarify certain issues relating to the outcome of a vote taken on an
ordinary resolution put to Novogen&#146;s shareholders at its Annual General Meeting (<B>Meeting</B>) held on
28 October&nbsp;2005.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">In an announcement to Australian Stock Exchange Limited (<B>ASX</B>) entitled Results of Novogen Limited
Annual General Meeting dated 28 October&nbsp;2005 (<B>ASX Announcement</B>), Novogen advised that in respect of
Resolution 2, which related to the adoption of Novogen&#146;s Remuneration Report for the year ended 30
June&nbsp;2005, there was a &#147;majority vote on a show of hands in favour and the 12.5% proxy vote against
was noted by the Chairman for this non-binding ordinary resolution.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">To clarify, Resolution 2 was passed on a show of hands at the Meeting. However, as I stated at the
Meeting a significant number of proxy votes, specifically 12,193,974 were cast against the
resolution. I also stated that this number represented 12.5% of the shares on issue on the
presentation slide showed that this represented approximately 70% of all the votes cast by proxy.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Given the significant number of votes cast against the resolution by proxy, a poll should have been
called. I did not call a poll because I had understood (incorrectly as it now transpires) that the
purpose of an advisory resolution was to give shareholders an opportunity to discuss and challenge
Novogen&#146;s remuneration policies. I incorrectly thought that if those views were acknowledged by the
Company and recorded then the resolution would have achieved its advisory purpose regardless of
whether the resolution was formally passed or not. I apologise to any shareholder who felt
disenfranchised by my misunderstanding and assure you it was not my intention to disregard in any
way the views you were seeking to express.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">As stated at the meeting, Novogen is seeking to understand the reasons for the lack of proxy
support for Resolution 2, and to this end has sought to contact a number of the more significant
shareholders who cast proxy votes against Resolution 2 to ascertain why they did so. If you cast a
vote by proxy against Resolution 2, we would certainly be interested in hearing from you and your
reasons for doing so. Once we properly understand the reasons, Novogen will be in a position to
determine whether there is a need to review its remuneration policies. We hope to be in a position
to make this determination by 31 December, 2005.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">If it is determined that Novogen&#146;s remuneration policies require review, full details of what the
review will involve will be announced to ASX.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Yours sincerely<br><BR>
Philip A Johnston<BR>
Chairman

</DIV>


<P align="center" style="font-size: 10pt">&nbsp;
</DIV>


<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<P align="center"><FONT size="2"><B>SIGNATURES</B>
</FONT>

<P><FONT size="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
</FONT>
<CENTER>
<TABLE cellspacing="0" border="0" cellpadding="0" width="100%">
<TR valign="bottom">
    <TD width="51%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="23%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="20%">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2"><B>Novogen Limited</B><BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Registrant)</FONT></TD>
</TR>
<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">4 November 2005</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">
By
</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><img src="w14381w1438101.gif"  alt="-s- RONALD LEA ERRATT"></TD>
</TR>

<TR><TD><FONT size="2">&nbsp;</FONT></TD></TR>
<TR valign="bottom">
    <TD valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">&nbsp;</FONT></TD>
    <TD><FONT size="2">&nbsp;</FONT></TD>
    <TD align="left" valign="top"><FONT size="2">Ronald Lea Erratt<BR>
Company Secretary</FONT></TD>
</TR>
</TABLE>
</CENTER>
<P align="center"><FONT size="2">&nbsp;</FONT>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>w14381logo.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 w14381logo.gif
M1TE&.#EA`0%8`/<```$J)0!(-3<R+G\G*8P>'H@I*80M+80W-908()0A(90F
M()0A,90I*8PI,8PO+8P\+IT>&9PI')P<*9PI*90I,9PA,:4;*YPI,9@S'IPY
M(98S*9PY*90Q,9PQ,90],9PY,:4I&*LE(Z4I*:DM):4A,:4I,:TA,:TI,;4<
M);4C*;4I*;4I,;XD),8A*;TI,<8I,:DQ):TQ*:4Q,:TQ,:4Y(:4Y*:4Y,:5"
M,:TY*:TY,;4Q(;4Q*;4Q,;4Y,;TQ*;TQ,0(]1`-&2`101@1*4@-630!66@A2
M6@A:6@!C5@!:8P!C8P!K6@!::P1>9P!K8P!K:Q)"1AY(1QA74Q=B7RM24BUF
M8T%66D!M:C1X=4A_@%1^>%6+BFF&A6*5CVV0E6>AG9`U.8H\0YTQ/)D_08Q'
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M__?W__?____O___W_____RP``````0%8```(_@#_"1Q(L*#!@P@3*EPXD)ZQ
M??[\_>/'L*+%BQ@S:MS(L:/'CR`SDN(7,:3)DRA3JES),J2?>Q'Y46Q)LZ;-
MFSAO[HGW3^+,G$"#"AU*=`Y/?S*)*EW*M&E'+MH$)G5*M:K5I1*U^/EW3U^]
MJV##BETI\4L7?/[T_1S+MJU;AO?^?0GPKQ^]M6_SZFV+CU\>('OXQ=U+N##8
MN'F&3-%W#Y_AQY"5.MY3)`D>KI$S:[89MX\1)D2`_7,LD/3FTZ@YQO4S1$D1
M+/EZ-J[7-[7MVPOC!FO=9,@6?O0BXON*N[CQTOZ6$6FBI(F0+STEUL-[O+KF
MN-^,%%&21(D0/"3O_E&W3OXQ3'Y2NBM1\@1(GHEHR\N''!]+$>9-DCP1(@?S
M_/^%Q95%$4LDT4032"@1!'CT_%-///S@,QB`%![VCQQ$K'>$>D<`<1D\_'Q%
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M`^*G%2&+[+(%23C=HZ_*V)-,]=`V84;(?I5K29S&BAFH),H)YZ>D#29K2966
M65!<V'(*ZG@1WA/7/L/V):RP%\%Y,&W**H341"7)%`^$,NFCSS>_1A>1FL0P
M^>>?@JY'1!!]_-,@HQ9-A3)!)5&)U,$RH=JR1OY26?'-,"<%Y\H#Y>SSP:$B
MU.;.XQ%$$K*ZZND@PJLF-*^VHY7[C[@&O:RS0KM.EU1$XODJ17Y>>BEH@D@0
M@8ULD2JD)<HU5IUHI+=>VC-#(<+,*)PE'0K?_L[$J9LV0B0.!W3<<],VHE2-
MT2AA.Q,5BS4^]+1CSSKJM(.PJG/*!*+COJA2R2-W&!*))K`P/A$\7NTSG(3_
M],E<=\^N)SL152#EZ4+[U+.Q/_:TT[;1P)76"R>5$'('(92DT@M%<>W*43WY
MQ$-/I;UX+DDDCD@2BBB]D".0P!--US(_JOLC<++F2YCX^?BT`Y/`A-/SOL#O
M"`0BMZ*6>X\Z]O1C_AAC($,8R'"`<]1C'^<R",)8<0``'@`6=/(/RR(HD5W8
M@8`+D$`)+G`!!C#``1]H@R88I[40L8X/K?D8[#[6G"$PJ">8(PAI.-%``O;B
M9*(22"CB0$`/,H"#_AX\0!CH((JX6"DCF&H')WBH`0]VH(,=:$`#P!"&,M0A
M%@*Y"YE\0I%^G*&*8`R@&,D@1@\`D("LH,X]XG"`,HS!`P^X1$\@-#,9.F\=
M9!S#`2#!`S7,0`8V<$`;,H5#!29E%0=``QH(8(N7J>I?`AF%&Q!0@A*HP08Y
MD`$,:A"#&.1@!"((`0<&P3BDQ,-W_RA&$;8#,MD%RD#,"<(?T)3`H)TL#A@8
M00?.8+Z#W&,29*#`"4SP@TYRL@8X&($*5D""!91A$A8AW#_4<8<P,$`$*=A!
M)SLY@QBL8`UK.($:9$``,X#"'C'+G&#\<883G&`&:N@C/&=`3S_&0)L\_NC`
M`5C1J#.`008\V,$(PB"/5Q'.5X)9!P=XL`(QW,$&,^"!#3Y@`P4L`A_YB,B#
M%.B3552`G@RP1:9,:"N)$.P?YWB#`\3@R3_*H`)I*,`$&%`"'J1`GA,8@R?&
M]8]UQ`4+2%BA*\/V)2(\01_[L,<1!5(NB<"C'K[X)P\D$`G(S29XJRB#`SK@
MQW#*@`(7V.`"9!!/%>Q`!@TXPR^,9#'6=4L\W_B&8RBA`0[(8`9K6($:TG"!
M"DQ@`A6P@`G>:8/"FF``IQC(.W0W-0F9(0T\<,$,)B`"$52RDB>XK`G04((!
MJ`(A;I#!#G`@@QQ<P`TQ`9^H=J8.,-"3`XCX_@`])PI1!^AB3SP1E4]@80%/
M,@`6;(+:G!JTBC`H(`<K>&=.ZS")[8EB$X,HPP$X((8<T',`=H@./N;Q#SXP
M*:C@;65W?O0=P2R5J3'Y!R$8D(82B.$=[F@0/L05"0-D8`:%%8,#R@`(38@B
M%*&PA!W*T``8E':#!J#$1/0A39^H91UN4$`-`#D&#H#A#'%P1"4NH8E*.,(.
M9Q@#`R:0AAFXP62E8:SJ[G&&#>S5BG:@0QWB4(<9U[C&,HZ#+F(8VAC@P`9I
M.($#)(&90LZ-(NUPK6EC&]&)RD"O9(!/IG0[D5;TU@:_#>Z;$-8)`VB@!CPX
MP078((G!Z*,V$M)%_AP&\(%.QK0.--(:/(805$"I<#U-^)$1M!$\@Y@&'V40
M@PTH$(CA''`FA'``#$+``QD8X`RAX%?4/A6*,Q1`!CU800X&P`BI`(PBOB@#
M`W"@@AP4@`R(\%YI2*.N=:@"$!080"NV-AR?"*P,%.7`'=H4-*)5ZR!G$*T-
M9""&O1K@'"8#&*1:.P/3)D*V^7P#6==``3L,!R(<[<LJ2.#)`HA465Q\ZC]F
M,8`;W%4&NO[)=-2BLED\X`,YB,$:$`"($,%#(EM(0I".<(37A0UL0^A"GPOB
M$WRHH@##?B!38^:(`LQ@!S^0@0,LT3.?"802!IB!"G@P@P)48FIQRN@Y_D3-
M`Q5T'!$-*V'NIL(I2/P#0CTYW(K/,((U7.`.^V`WS"R6%*T!N\0P:`,;]IH&
M,WA+@:%*<C<OD`B(SJ`#F(!#L6?@`%%@B\K\L+)O@6NLB=SE'NLH0P=FT(,.
M&$`3+]_BRZ:&)W6400-KP&L!B#RG8`3!24KHMWB;TQTB).,@YDL*'29`VC,,
MI!X-LD4!WAF##X#!%]ORM:XHHHI_SK8!OGA800YX#S/<=09I`$,GE+4L5T5L
MH_PX2K4*?H\RJ,`%);B#[5H5P;\9!`X7X,$'XE`)!F2R`X2`'+`HTEKK,KT&
M]`2#(M!1[A#\P`.FXRA2>!L#+'/=05R42!R$_KD&1W,B4S)"EHQV9K![M*,-
M#+`!QP>P#HC40Q]8,(+L?A2[[C#!25T`G$S0T8%.BL`2,4,;[1`&.<!Q'D`&
MY'`/]``NE;(HXF$Q_T`+!_`!:9`#'5`&OS,0$A$(#`!/-G``N%`MB*(HMM(X
M46-2:+$K\3%S,:`&%Y!=CD$U$.,8(C)E!>$&);`&'&!X-Z`!.\`#!G!]1I-T
M2G8!B$!/.>``G88(#[`#+-`!<0`I-!(O7)%UO65JWR:%\+$*#9`&>54`G:8[
MI3)25R,^^.`+!U!B,\`!=*`KGL%**_0L3A`R0L`-F$$P)'$7_\`(#.!C##`=
M$($LBE``)9<&`^`*_J.A%D8T&A$2(1)A,5_!"08@!G\T<5)H,/]@"PV`22<P
M`*!@,H\2'PV(B5QA/C[12R%B:YUW5QU@!XV8,Z=2@]+D!B<0`V(`!UE7`)DF
M`V0@'L$Q&.*#9*X5`QV0""6F!@Y@"`(1;`+%`'(T*A`S$;`@`5O')B11)F>@
M`LBW!F=0:RE#(I+`7FRP`@D0#N03%U?`2F`3.T#2!$8P!'D0'KM"$N9R!B)0
M`Q,0"/_`8/ZP#^_P`#*P<;K6$70`!FM0`A]`!@W3//\`!R@P`1]P`G6`$BLH
M(>W$`R6077@H$WC(,M(D$&]0`OAX8O^`"&!@`C/``(!@,ALC-<L&!L9G_HS-
MQ@".(!!H6`(]$'KK0"=L$A-:9WVLMB?M,`#6E0,)\%F,13>(TAAE(`-DU0&#
M$(U_``1$595U=@13,`4F\X!Y^`^MP`%J,`)9IA82<0D*``-Q=P`[B1'S99-I
MN%<#(`H$$1?I4``1=P,4`'DGP5@!XWE/YXHQPRY46'L&(6TU``,G5@^MEP9[
M50#?YSB#(8PS@`-,=XP.L`B0<@D-4`(S(`)M$'F801)9QVU8N"C+<@</T$T?
M<&(?*301,3V:0`$090.]^(NM0P3U%S;K<1]%,`1_()I),3UV<`$K,`.#1`^H
MTR!P,`$QP`,40`B+DA&WQ`'6]0%M:#`-0@@R_O!.#J"/Y]41%<EBK.B*)S40
M,JA%14.+&R`")Q8/]W`.`Y`&:2`#8^!39%DLQ%>$,ID#SZDI;N``$:4`EC!?
M,I$XTDB-.9!E4M$P<-`!.,`#!4!QK6E(,8</ZS`&,%!8'#`.P"$1RR`$86*5
M0.(:4]*/`3,]8'`"*^``:+=@$N):R;<+*H,NHG``?B0#&`@Y@O$/H757',`*
M,<01CM@XG2=;K3@U3U4NY7(4)S.C!&&8[#EE]757$C"1XA.9_Z!T,V"$EJF,
M!;H.83`&U:<!X^!(MF*%U:>@C1,B_P"3I/8`U!`=WZE`:($41P('([`!-B`!
MFQ"`_[`'=^=O0E5G_BVR&.."-)-@ESQ`!NXP)V=V"AWX1V:0;,_S#P=0`CLP
M`QH`#OB@#_D`=F,P`QZ@!F)@@R$AA@$3;!B970<E*9I2F"*Y`209'`VI`3T`
MH2VZ-1&B=,Y68CG``=`9(@+#"0,P;"=P8C*!++N%H&JJF-,1#I0(`SI`!N_`
M8*;J--<(<X4``GI:`H7@#SQA,%D0*%6I;[*3($%`#*71&/]P!AV@`C)P!Q"#
M%/B@"1,`41K0AN6I$131!G=E`P70"NW`*[IP`3(`D&\P-1-*-VKR*7T)4"5`
M!Z=@"J,`"J,@"A9;L14[#;9'$.H9I:^R"Q\``SR0!@2U8*'";$LV;%OJ_J68
M&`=IH`(`.PCF$P\,)AX_J::(\@^N8'F[I(4<T0GI9P,B,)&Z^@U2X"=`PB)Q
M6`27P:[_``L<X`(J8`"]`#%)\0AV176*\*I(Q!.`P`'X10&;,!$RL@KI]W3>
M&4T+!T,[$V<HR&(;0$\=H``2(`(2`%AX.P$1$`$$D%WL=A!0BJQ)<0^:P&9$
MVP;MX`[:X+`#*`.4V700=0&8*1C"X@]C`+GZ)%*IMUM7Z&VF22*LT(5/!P=`
MR[8#P0E#*P)1N#43$0RX*3NN4:Y%D`6](A!W<`&2973E21&'()N:&@G7BA&Q
M`0@:`'H,D`E8ZPD4`%`3H)$6$9EUXG.]U#RW_N9-?60#:K`".*!-G:1-.3`!
M@L`S3QJK"2LL\!`7;G"\.:``514/M"$0ZP"3,T`!34=/%^"RPG(/H6``F8JC
M+^,3K'"%.BNZ!J`&F62ZT9@R!=$)]QJ^;;@U_M`@WD4V0\5"0Q`A6C(&\>28
M4I@4CL`!$#4!"O8H&T$1=7`!^)6\,<,/:*M^(J"/.YL;A(DTZ12>9^!-!]D`
M%,``"E``"H`!0%P`'(!=T8$0@^MIP&&AF0N7G*HWZT")*SNYF,D8^Q@\=C`!
M?\0`P>J35]:L)*(+8&!))]"--I,R%'$RE2`"$X"/\AJ8[^,70'`$02)4ZI&N
M)A0*";`&)GMMXQ(A_I(@PCPP`5'II`GS#W5@26K``)[0PKIP:1C9AB:\$"G(
M#^MP"9-@"9=`#;3&>F8@6S)`!ZO0"=NC"@!FRJ%`RLN3,8(KDA-`DF;[*)O0
M`&J@!AIP!KZC15',<?;+LOD;08Y($6Y$3P40"C;3"A50C5WW#^3P3SEP`F-0
M@EXK-,$I$84@`I`[`95+<!2A!W<7HJTT!'H0/&Z`D0,9F)#""0@79J8;&R=\
M)&V@A@S0"@>$%.$`!C:P`BLP!H2)*[6!"P-@``XP`"Y')CBL`6DPD`P15W-J
MF(@YA#,1!Q]0RP0POO=`,.T@Q4:(25M:Q<S3,@!M`]I8!G&!LU]\?4D)_FCC
MM`9@@(BOHI2N2XLV@`,3L%-#(Q/V0#!XP"1Q^#%&P`4"<0X'T$=@@`MW\2_T
ML`L.D,\S0-*\<L+W8*,<EP;A0$?P\`YE``,KP`-@<+5%TRU:,@X+P%`+D*NL
M(AB=I[TD('N@&"+?<HU7#!."*P,CB1Q'3!M@(`(\D*")M2M:RG2^[*4S(1XD
M0@@<L`,]P`!U4#>U0`*E%5(C)1T-R5(I6;G8QA!-A13T<`YA`%$QP`'A("X(
MPSP4D0<\K4)'\`1&,`4R,@@B$`,E@*P(E#F,<P#(177\)".@$D.8PD7XT+_;
MBZ/PD3O_$`<`Q=6(`+2U5!I)D0L-L`(_0`%H_D<F*F:1,G"0=N!(2*.L:?.1
MM)@!,@#+D7(7^"`*%,`#,+`!8S#!_&`/8+#7%(`(A=71^X@0[5`&+$L`H:`6
MLE`!CWU].TH1EU``:S!A;(`4UHK9J/H/B[#.(F!X>KAYD<('5,D<+1)43\`$
M1O`-_\`&(1`#SGBZ*!8'(O#,'!"%Y&L0)KPS<,`!^MP!^D@B#<()$N!'%Z"0
MH8(FO@0ION``)\`##O",,.3)DYM=7UT12>Q+7R$("&`#-!`!1GL/8M!HQ>AT
MO^RDPFH+#D!6:@`&E@,+"]"<H-LPPM(.M`P#.=``G>!UB5(Q4EY:D\4(^``B
M*BX0^W`7?1`$K+2;_LQ1!,L@"KHX`V/0I`TK(Z)``'@E`P>`#B/E,),7M08I
M3@[0"G;N&`T"!A78Y="I-(##XX1(=10W$ZAJW7\)<AUAF*^,$$KEGF4@`C``
M`V`P"CT%DS$`V%1<W]S<&)0P`$^F!KC("@;``SPPSSU30O]`!V)0XF)`!KZ3
M6PM!(Q!("")0G&I@`)9#Y_D3'3+R!T%`QT^B!$10"G;``,,^"'7JM0WB#V*W
M!EU^G>6"*!_IUG'1!A<03F+0C50S$XQ@`%XH`P40#KV"/P/1,+[0`!'%HG32
M*7U9Y-.<$>KYT+Z4-;M``#S0`S=N#^K@`9@$V'=UY4@W$V[0`6L@`@9P_@F[
M8``QH`(%L`L.:S"Z@X8(_`$%0`?XT*@,,<%?L0J+-P*)+:]/C72NP@]_``5T
MW"1+0`1Z,`8V``.8MR>L3!":X`"0I08%0`GM4R/QS@_MP#B#(`$1I08#P$^^
M1`:R=0(XZE/M0!S2E!2^\.E!KBDX/)ZFSA%)_O$\80@,``,S``9P<`]CL`&U
MWG3&5\55@^#_$%4P@`..=PL&``.)C=*-(1/<10@2T`$VL`,20+,502*^(/(Q
M4`,B4)_.$^\TB&+$,`3T=P1+@`16D`;WF+`0T@_.LR_X<`9JF`,'H`I7/\.K
MA2R9D'$<IP%Q4"5(%PH.EP,UP`%F<`Y(T^F@_N;C0"[D5:**9L#P1\X0(5G7
MAA01$-(.9Q`!/8",GS#?'+_(VTQP"$X1E%``-"`#:4`'7P:A6;BCR38/^-`&
M]ZH"+\``\CIEH@D0__[Q^X=/H*L#:UK`^*!`U3U]_/SY$UA1H#]^]?CAJ^?O
M'K]B1HXT.:($B14U*Q1X^O=M(C]]%@5N/.=@Q@P9'PYT*CAPIL]_^PC^H]0@
MS0H<(L:HHS?4(C]X^`XIL&$CC8P#H@3N>UJ1'\%=!7C,8'!IH$%\+_'=.R-C
M1@<[00E2_$?7;EV9%=^4J"'#3=Z!^B;NZ_9OEX8<,R:T81,CQP5$:6RHX4`(
ML$Q^]_[%*6&C1@:K_FH*Z+IX&=V!-#M<D'6SZU_3?)GYT8M7T5"!-"=RP!@@
MJ:[3RS+K5?P3I"23)E9BL"#3,;C`>`13#;`A0TT:`G;Z_:NGK^E7H3'1T5F0
M9H8+-0:T:LPK5*`=`VB0REA`9UQ%S:_Y[:M'[]XN!]1P@0*S-.+HMWKN,6,&
M-<2(*Y[HOM(HHNXZ\B<VP-PX0883_GK.(D@6\`$&&FP8ZX)$JK+!`47PJ2TX
M>EZ[!PP;<M@!)S4<@*6TR\89HX,;<^``C#IVI$L@?-29A`P%S,NA@P$L\X>]
M(S\<CB)^^@`""2:4H,*&%.)Z[;FO[L&'$P,ZP&F&-,!8Y)R*#!)(G4'`_JA`
M#=W2*."3!,?,2Z*!"C$JAIO$*``.3LK!1TXY_VGG$PUF6($!308BR+F,V(+!
M!@[JP*>=1=U9JQY\WFF'U'ON82^O-F380`8XAOMPIC8FP&&#&4Y$Y*8:-!C$
MQ>=B)(@3L5Q8(8T<=.01,X+.:8.!"6+0;0(.RJ"CD4LB"00.#C2088<=<CS`
M$H-FFVM62PWRARLOB%#""2K`F$`</X.[QY]X2%U%WAS&4JR#,^QPQ!)'[#B#
M@0MRY2&'",)HY5/G`*/HTW\F.6""'%;X@8<8"@#C##CL($01.^(X8XP"<EAC
M!THMG1+!>\H@E$TVRBB##9QS7B-GG.&XK-4:_C!PH]$/[QGG@0TFXX$'%)=>
M88)"%D5WHSHN6&&--$1KI33@!(I(H$8,X"#7-1R+0`,**+C@!!5<4($'&0HX
M@UY\OOIJV>=DG4B@*8I00HHPVD`7+WZZ(74=.@KH0.6E99C@\<?=:KP#`NIX
M9RVB9>(*28/"2;R#$WQ@X6H19+A``P9*V%"--5J?8(!)?L*4'GS,6(&'JT]0
M0X8.>.>]]UX_^,"!,WY.80(>WL@\.(HL.<"ZQ#I(I/<."C!D\#'O"4,,R7+<
M$2_`5O5''3L.:(`#9&.HX03<5U"CA`X,..,3@=@;JLI9G=*LCR&>D.*`4&QN
M5ACA1SS,]`]8Q*$!_@V001IBL`*%+4T-'6C``>+@BX+(B2`"E`E=G'**.)BO
M`VIPVEC6,(/6I4$,%%B`!5T!E"MEJ@P7Z$`:+I"&$N2P!.\[01I,L*$<BJ$,
MEWE#!330`0\-\&5P$(,8;*`!#MPA#G"@`QPN`9/!<444!O!`;@H`B[KAKR*7
M@PF@[G&).+"!`A.(``0@$($.?`P1O7C*WH[4M<M@*2.D^D<6@@`%,NPC)OFK
MRT2Z\[5Q2,(-8]!`!"*@@$>*``QPD`2<A+*/&.D1,.J:B7O^L8Y)Q(&1#%#`
M!"0@@0E`L0QN0(0H\@./C1P((PDJV12G6$4ZT"$.N:0B+G-I!SSRXPY5_H3#
M(K[VH9?4`QUB8.0&'(`(9J'K2&M)57Z>HQF-W,TBZX`%*T0A"E?0\4]W^0WV
MD.23>T`##WH`Q3_@,;C[6:IKY'"%*+SI"G)$$S,2BR97Z+(.5]3S%*+H!36L
MZ969-"HSX,MCG"K"P:Y$=(#ZDUJ,S'E1C"(4CQE%ET4/RM'@;!2D4_O)2$UZ
M4I2F5*4IM2@Z5_I2F,94IC.E:4T%\E&;YE2G.^5I3WWZ4Z`&5:A#)6I1C7I4
MI":UJ,`1XU&KU%2E1E6JYF0J5(M*$:M.5:M;9=Y/1(K4K')5K#9M*4CM%E2K
M$D2M8V4K3V-45HS6`Y/9_&I-]U$WN,[$;O2`_F5;_2K3CU0DK]@KX-?"2E/-
M#/:LEX+H7WMZV)4N3[![&&Q7>_*/*Y`B.H6<*4Z?LH=V5.2.=R.%%@+KV)AF
M9B+>H<B]L,D/>]!#(_ZYQSS@41N,I&JA?/U'8NGAGWHDJ)K!314^X)&@?L#D
M'O;P1S;^X`]C`*`74YK-/6B7H'WDXUX8H=T]NK&6?TBA#_>BC3OTDRI_T*,=
M[8AM;SVB6GM\92WV,!-MZ$%?XM)F'_'MAC^NX8=_7$.Z]\UM/YKBC_[Z(0!U
M86Y=49O1>Y5Q)G2)B$4QY)^[$?`?Q^SK0-YI*9^<%4M!V?`WAM*%+OPC'ER9
MAX1IHU>N?&0X6!3(_A``/)#^;%@B]M#QC+\1$7U$1*V#M*C=*!*1=>W''OKX
MQC_T4(5_=(,>R1U(DS$2$Y?X00AZ'>2#4TJ18U2!"U&XPC+X`0PJ1*$+W+C"
M'O[AAR`LXQ]SX$):-KR%*&A!"V[60Q2BL`=^>($+:=8#/?0AARA0H13\T((7
M%+T'*`1`"_K`@Q"B8(5A2.&=<_#S'/CQ!RJ,^0J%H8@TJN"%2Q?C'U/H0IH!
M;`HJ0*$*Q_B'%N0`A3]400Y!R$(>J"`$/_"#%+&^PC&"[`4H1*$:UK`"%+3P
M#6U$P1K_D,,7]B`$(E`A'T(H!S_X(`4H<.$?5O`S']Y,!'S\X0A`F(.7_E6J
MF6P$``_QT#4W<+V/*O#!"U[PAQ>*D(=QNUDS>9#"/DH!!#Z4(@C?8`84MB$'
M(WCC#P#P!L$_#01^9$$(P-"''[2!63QTHPM?^,<P`J`/+<7#&T#HPS"`L(=O
M"$$//=$'`/#`#SE4@1]3R,(WOC`%?)CB#_S(0Q7\D04CE.(;4I`#/ZI0A4-#
MV13$P`<>=*Z%*V@C&DX'>!:ZH(\`7(/:6OA''K#0D@#((Q@`^$,]3,$/-\=[
M'GY``CZDP`=X5,/=7_[',@+09#EL(1E!^,,PO`YJ?U0A#UG0!Q1(_0\LY$&N
M4^`#'K(PC&%$X0]SV`(_LA$%96RA"W_H`Q2R_H$%/,2DXWJX0HJ]D.)E!"'C
M<KAS%Y(QA)AL00X:%`(R0++ENW^:"C'Y0QZZ`&7%X^,;5`!&'VG?!RL0I!1Z
MV,(5O@$$CG^%Y7^P>CX"@`UJ9Z'L6*C'-P)`CR^(?R;9V(,>`G`,NH\;"]MP
M\-X'IYEE`"`F@6<&$`3MA3UHO&08OB@8ABF0",V(/('(MSFH@B[8-V"8`_'C
MABAHABQH/4'3ARL`N'V0`BWP`RQ(,2Z`/=G#@G;[!R[8`F?`.!2D/74)`&3H
MAVY8,/%ZL^%KM3R0@^C+MWOP!BD@!<@#.#Z`LD'+P2KX!@"0!HDPORT0-#V(
M!R#X."_8@GK(@RO@_@?OVX<MV(*ZJ`<MP0,M@8;XTP<O``"2L[^1PI)FT#]J
MXX(U'*2OT((M$+<JV((OD`B*T((NP`=]$`(^V`,HPPLY(#MXJ,`NJ#."T,"9
M*X63T\(N"#38@P)]Z`*RPZPY0(8A(`@N\(*Z"8H`:+L_$`*[ZX,WLX+K&X8L
MH0)^P(*96[I2P(<L(+D^H(+K2X9_X(/A@X(;XX=/[(GKRX9_V,)_P(,KV+``
MT`:K&Z18-,9H\(,AJ(AGV#(T!*DC6\/:\`*R&S,]T`)2X`<]```WDP,@^(,8
M^P=A"(#`$X(\X(<\VT9Z&$2H`(!L\#LOP`.RLX(]P`=M`((O^`(H\`)J_E/'
M/P`">.`&,_0"('B&80``@F@T]M@'(J@"]\.#?X`"<_,#*D@\+<`#*:B"?)#(
M@8@"`+L"VML#*OB'*MA(*;@"?=@#,]2""!0"/.`"-Z."U@L`<>,#*/@Z`-`&
M?5C):M,#*+!"*`@&/X"">[@">RS&:>0H+(&'/:B-4BB%(/.#.=@#C&`_8#P&
M/F`'0,&'?8"&.8B&-H,)/9B#=BH%4MR'/8`E:=`#/%@T/X"&@3"&.?`#8^C&
MEM0#;0"T?]"&.=`#:]`']B,(4NA&O!""/]`#/HB)/9`S:`"T;-`#P02T/:"U
MEGPG/PB&?Q##>]`&RC0&/]`(NVQ+E+M*\%,GU#W(RRB#RW]H2W[HRSGH1JLT
MACW(!FEP,U((S"9KRHS:FXV@!Z[("`%JL;W"JKWIS&@H.2!8-&TBH-'JB<UY
MKW-2E8*(D501+#GQB(*8"W\(@&R`"(GX"HLRD#&Q*'RIB^WXAWG8BJ$0+FNB
M!PRI"VL:#N,TKJV(D]\:B'RY*;62%=^\*')B*+RY"ZQZ,UDS`CW0A\TBT`-]
M*KQ("PGU!PGMK8+PB`FU,_P1@F7P!R1#"PG="`JE4,W0L)?@K`BE3PM%J+H`
1+X/X**S*T,LZH.$PB(```#L_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>w14381w1438101.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 w14381w1438101.gif
M1TE&.#EANP!!`/<``/S\_/O[^_W]_?[^_D%!0?KZ^O3T]`("`O?W]P<'!_7U
M]0D)"5-34^GIZ2,C(QD9&?GY^3<W-^?GY_'Q\?CX^.7EY00$!!H:&A<7%^SL
M[)65E5=75S\_/\?'QUY>7NCHZ"8F)@4%!3T]/2LK*S(R,A\?'R$A(=[>WO+R
M\K2TM._O[R@H*-O;VZ^OK]C8V(J*BGY^?O;V]@@(".;FYB<G)R(B(M;6UC4U
M-1(2$@\/#ZZNKMS<W#X^/AL;&U)24GIZ>LW-S7U]?;JZNDA(2`$!`;6UM<S,
MS&EI:>'AX=/3T^KJZA,3$PL+"^[N[K.SL^#@X,[.SNWM[0P,#-G9V9:6EG)R
M<D!`0(V-C6!@8&%A85965F9F9NOKZUA86%!04%%144Y.3J&AH08&!B\O+S@X
M..3DY`T-#<'!P1X>'A@8&-K:VH*"@G-S<W]_?UE962DI*9&1D3DY.>+BXI24
ME-W=W;&QL;"PL+V]O=34U+FYN:RLK-_?WZ*BHH:&AJ>GIVAH:)*2DG9V=H>'
MAY^?GTE)28N+BW%Q<6QL;"0D)-?7UV-C8RHJ*@X.#CL[.T='1RXN+AP<'"`@
M("TM+45%1145%4U-39R<G*.CHXF)B<_/SSHZ.C`P,%I:6F]O;ZVMK<;&QM+2
MTD)"0KR\O+BXN!T='6=G9S$Q,;>WM^/CX]#0T!$1$:NKJ\7%Q:BHJ'=W=Q04
M%&1D9&5E97M[>RPL+,G)R;:VML3$Q$-#0T]/3UQ<7//S\R4E)<O+R_#P\*2D
MI$1$1(6%A<C(R'Q\?)V=G75U=<+"PM75U9.3D\#`P)>7EU5550H*"H&!@1`0
M$#P\/(R,C`,#`ZJJJE145*:FIIN;FS0T-%]?7[^_OT9&1HZ.CC,S,YJ:FA86
M%IB8F+Z^ODM+2VYN;G!P<&UM;9Z>GG1T=*6EI8^/C]'1T8B(B#8V-L/#PUU=
M7:FIJ7EY>8"`@,K*RF)B8K*RLJ"@H%M;6TI*2FMK:WAX>+N[NX2$A&IJ:H.#
M@Y"0D)F9F4Q,3````/___R'Y!```````+`````"[`$$```C_`/\)'$BPH,&#
M"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($.*'$FRI$F2>ZBLH:(AV,F7
M,&-"S`##2@)_./TEX"!(E\R?0&.>(-`/C@XC>(#4<87('R)>0:-*_8C$`2<%
M!P/8Z?$`RM2O8"DF`4%(B<)SD!A,",NV;<(8BN#)85B'"0RW>/-VB&-$3I$1
MDD28PD"@$SE#702A(K!I;M['4T_`H)%3YR0"!*R)"%&9"$XL$""+AJF@R)8'
M"XC@.')ECKK0`@0(C"$;"1Q7/G#X<W:L2*_1P#_&Z"9"A@4"+2B4&A71&)H%
M-YC(\&$VN'6+*K*8(>+%4_4,E5Q$_RP`:U$#"=LNS-(0X[K[AP+TT`!AZ$P`
M@J(0G1@X`$@9ADZDT8%`MC1RP`AW"#2("/N]YR!!'=30!E8&70(&A?_8@$$N
M#!6P01``"#1`*Q<LXX<`5%C0RH,LHO#%$/<=E`D8&0QT0@EM-/0))780-$,0
M2Y`PA`7*L.C@7D<TD!`=5NPQT!07'-(0$C7\(1M!R%#F3PD-&@E<!AXXTD&(
M"1DQ`AT#N?"`E`SI4@T(3Q@D`0\XR3*`EZ,!H`@E0#"DS@IQ"J3&!?HX5(@9
M?!R4!4[FX2F:`+'00Z9"%7`PQ4"#?N-0`6Y$H$)!`:PS3!9,".'0'I<Z&A,$
M#.#3D`'2&/^#:0\</`3(,L44%$4E20@1P@L,32."!0^(I^I+7,S20D,4##%-
MF@]X\%`JKRQ+$"@C))(L!G4H-`$).<5Q3!/'FI3"`M<T-(`//PR$!R6#/"2'
M`QH4E,(N3Q2@B3^:_';0`,DD``T/'A072A3E$E0!.&=T],,C,SAT""=D)I)&
MH@X!T(D;!8532HC2^"/%)P=1`(P,(531WC\&I+)RPO]PXH\L'871IT.U:%.!
M0&H^`]$E'(0V4!>&"`0'3LP8)$`V,OC#@+\,(:/-,`\V@%,V0<VP"3L"W;&"
M#1`)$0'"`@E`0#L"$8/#)%]<.=`X9OA#0\0-V>"`/[@\J`5.H@3_I3$GLE$Q
M@I(/I?!`)@.AH(D.`@5!@A`KD#Q0`$/@!*Q!"@R#YD#%O!*!%%^XUP`%$BSA
M3P1W!G7"&,D(4(@S!D"$!S?E#(2*%2P(I$$-K#C@BT!3R*-'#OZDH<$6&S`@
MC1>51-`#"8P+]($J6_R#"QAX?2#08C4\4L,K-_AS`&?^A/"%%EXHPP`'5\2T
M#0Y^.$(&"A!]\,8:`X%"QG__>(*#'9L(PS_R0+S*Y"0';R#$'[9!MX%@9BV.
M((#?N."$-O``#%4`1AY<X8\@_*,"/?#'+GZ0@A;PP@:DP,D1P!&)$130'R2`
M@2(VL):2C()XH4!`1`H!`KK18@P[^T<9_VA0!2Q\`P%/D$7X%N`%-J`C#SN8
ME$%2D`.P_8,8'3Q(`Z`"D@$$`Q`/P,DD_O`&1$C",_ZP@@X'X)."[,T?N1-(
M`2IW@!;HP03^$($.20*`%QQ@!8F(B"=`$$0[=*$`(O("&B)Q"Z'IP!^'B-%"
M`B")!`FD%OZ00<,*8@U_K,@CJ2`#3G@@CG)(\0<Y$41";.$/;F#H'R_PAP3_
M(8'P5:\DM%@&(Q9`@%JX;2'Q.$`W!!*(I`VD%#BAAD`4D`M_M*LAT6``078@
MPC=(\A\NX`S6.,(%+_AC"W4(5$$H4`(:Q,(?S8BC03+ACRX41!#^`,1`#)",
M59AD%:H0Q1E6$/^">73@F@@!0@[,(1`&M&\@HUA`&HPU#3'X(Q921$@&T!`O
M=_E#&!;8XS]HL0)_$,$("SF%.!M2N5LH)`K-8$,A0O&*Z!GD'OY@0T&0R0J&
M[&!S'/%`#]3PCRC,(0LX&$,;@,`""B"D"6-09@`:80F"A"$$/KA/'DJ`1U<T
M)`R$*,@J%D`%9PP$`8U8P0/$H,Z#N$`,V'B(!G!2!86H8`F>^`,,'!"-@R`@
M#OZX"T'J(0;M40H'#O`(%F;A5X$T`!,,H,$!$H"-6KSR'Q2(`QS^H80;I$L`
M1E#&33;PCS!00A;%D$*.&&*''12D#R;`Q"($P@(::&(&6A"#:1.R`7___,XA
MD/`'$VSA+0PX`1>9D()7"J*$+^"$30(Q@`E6NQ`#8$&F'/E6+A!Y$#D\`PM+
M(((#NM""#KP#`8YP0PSR@`8^!.)NW#"$.$20!!,$H@`&N`$88B>109A@`UGX
M!P!XD`/M$>``LD)($ORQ!,(Q!`+^L("U$J(+2OA#$3H(Q4$B@(-KD&"6`GFD
M%.@+$Q8X`&,**<,J7N`##C0M!`<X@"12Z`\Q@.$93J)#"1ZP"0D(Y`A,<,)$
M4H"34WS@%_ZHUS]0V=2#>.,""=B%41LR8!(TI`3^<(((;DL0=L3T'T&P0"`%
M`@*<;!DFWBB!%1\R``J@8AP8^,(28F&$+OVC_PFFB.=`D/`&`4D$%#@9PP(N
MH`&A?2`2I*`?021`C@0PX)'".'`+'N&/!9A*(0K`@#]\$(D@"F0",&B&/>@G
M`0PX8`=1^,$!I."/3<(D"(2DB`IN\`@F%.$@10B$@?\!#&A40J,.04).TI&*
MT_JC$M0-@!]R2P8)```#"6B@0080#5-8H`^=1(.;"Z*"VL*PAO\H@!["1PR"
MS"$G%@B#$/PA+9B@0!NY`.A#%$"G&B#!(5QH!!$\(&B'7,$?)GBU052P!7]4
M`P:8B+,,"I$Z=Z3QL?]`03<XX!0G#0#((*A#8052`3[@$2<8$$0'H$`%6.CV
M$D*3HR1PPC$#1,("-O]&R)([,@4T?)(B'O`'&7"]D"D08DMK^-1"8G`$?_R"
M?P>!@`=NXN\^X#H#5O"'`_HPAS68@Q]58`0DTC$';$_`$3F)`#PZ00A&X.0!
M$4C!"Q:0DP2H`A9C)D@&1B$*,IV+`QPF2!E(X1*.!*`=.[6('BZ0:(A,X`J,
M-@,#]H&'#*1.OU``A`\68`9+1/0@MC#$)1*B@0L8D!%K4/<_!(".6T"C,A$8
M0CP((@0XL((5!CA\0]QPNK1SP1(]<(='&K"($52G(JJ'B`+\H`6B'^`"-3!!
M&N(VRB1L)``I\,,IJ%$$G2M$`E!X1Q)XRA$$Q-(?C%@"&4"08DQ0ER-(Q<6O
M]V4"@#O`8AT>F,0M-J"%(U1A$*"`64&@<`153`(+7<@'+4#"@A*<0O[N\7@>
M(0"!P`$U`H`(.!$2,`+'D(`.&!&?@`'(\(`4R!``L`'N5H$:B!!*,`)_((`;
M6('GL`(W$X(F"$M9$'(GJ(&\``DZMH(AR`P10"XPJ($9T`B65(,5N`,,$'<Z
JZ(!G$`X_6($J@`T'-80.:`2*0(-(F(`%4&]-&(52.(546(566!`!`0`[
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
